Choosing a Kidney Function Estimate

Creatinine-based estimators are population-derived equations, and each was derived and validated in a different era and population. As methods for standardized creatinine measurement changed and evidence accumulated, newer equations replaced older ones for clinical classification while older ones remained embedded in other workflows such as drug labels.

Current guidance organizations, including KDIGO, recommend the creatinine-based CKD-EPI equations that no longer use a race variable for classifying chronic kidney disease.

The CKD-EPI 2021 equation estimates GFR from serum creatinine, age, and sex without a race variable, and it is the recommended default for CKD staging in adults. The MDRD equation, developed earlier and from a predominantly CKD population, is still encountered in older laboratory reports and historical comparisons, but it is less accurate in the higher normal range of GFR than newer equations.

These eGFR estimates are reported in mL/min/1.73 m² and are used for classifying and monitoring chronic kidney disease rather than for calculating an absolute creatinine clearance.

Many drug labels still express renal dose adjustments in terms of creatinine clearance (CrCl) rather than eGFR. The Cockcroft–Gault equation derives CrCl from serum creatinine, age, sex, and body weight, and remains widely used in pharmacy practice for adjusting renally eliminated medications even though it is not a GFR classifier per current KDIGO guidance.

Because Cockcroft–Gault includes weight, the value is expressed in mL/min rather than per 1.73 m², which is one reason its numeric result differs from an eGFR for the same patient.

For situations where a timed measurement is needed — for example, to inform a decision that depends on an actual clearance rather than an estimate — the classic approach is a 24-hour urine collection. The creatinine clearance from 24-hour urine calculator combines urine creatinine, serum creatinine, and the 24-hour urine volume. The result is only as reliable as the collection: incomplete or over-collected urine is the most common source of error.

In practice: use CKD-EPI 2021 when the question is staging or tracking chronic kidney disease; be prepared to recognize MDRD values on older reports; use Cockcroft–Gault when the question is drug dosing per a product label that specifies it; and reserve a 24-hour clearance for when an actual timed measurement is clinically warranted. When reports disagree, the explanation is usually that they are different quantities, not that one is wrong.